Geographical distribution and disease associations of the CD45 exon 6 138G variant
Victoria Ward(Cancer Research UK), Elma Tchilian(Jenner Institute), Peter C. L. Beverley(Jenner Institute), Branwen J. Hennig(University of Michigan), Ritu Dawes(Jenner Institute), Charles R. M. Bangham(NIHR Imperial Biomedical Research Centre), Adrian V. S. Hill(Jenner Institute), Warunee Kunachiwa(Chiang Mai University), Sarah J. Dunstan(The University of Melbourne), Anne E. Goldfeld(Boston Children's Hospital), Akihiro Tamori(Osaka City University), Mineki Saito(Kawasaki Medical School), Nipapan Leetrakool(Chiang Mai University), Kouzo Hirai(Osaka City University), Henry A. F. Stephens(Anthony Nolan), Hideki Tahara(Osaka City University), Julian M. Hopkin(Swansea University), Walter F. Bodmer(University of Oxford)
Cited by 9
Related Papers
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
|Nature Medicine|2020|643
Host Genotype-Specific Therapies Can Optimize the Inflammatory Response to Mycobacterial Infections
|Cell|2012|577
Widespread seasonal gene expression reveals annual differences in human immunity and physiology
|Nature Communications|2015|535